Automated Liquid Handling Technologies Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

The Global Automated Liquid Handling Technologies Market is projected to expand from USD 2.18 Billion in 2025 to USD 3.75 Billion by 2031, registering a CAGR of 9.46%. These technologies consist of robotic workstations and instruments designed to transfer liquid volumes with precision, effectively supplanting manual pipetting to streamline laboratory workflows. Growth is primarily driven by the rising need for high-throughput screening in pharmaceutical drug discovery and the imperative for reproducibility in genomics research. These core factors underpin the industry by reducing human error and expediting experimental timelines, marking a fundamental shift rather than a fleeting trend.

According to data from the Pistoia Alliance in 2024, 68% of life science professionals indicated they are actively using Artificial Intelligence and Machine Learning in their labs, signaling a major move toward data-centric, intelligent automation. Despite this momentum, market expansion faces a significant hurdle due to the high capital costs associated with these advanced systems. When combined with the difficulties of integrating complex robotics into existing infrastructures, these financial barriers continue to limit adoption among smaller academic institutions and biotechnology companies.

Market Drivers

A major catalyst for adopting automated liquid handling systems is the surge in R&D investments by pharmaceutical and biotechnology firms. With drug discovery becoming more capital-intensive, companies are driven to deploy robotic workstations to boost throughput and mitigate expensive errors linked to manual handling. This financial strategy enables labs to acquire advanced dispensing platforms necessary for maintaining high-precision workflows and market competitiveness. For instance, AstraZeneca PLC reported significantly high R&D expenses of $5.79 billion in the first half of the year in their July 2024 results, highlighting the immense scale of investment fueling the purchase of efficiency-boosting laboratory technologies.

The rapid growth of genomics and personalized medicine further necessitates automated solutions, given the strict accuracy demands of next-generation sequencing library preparation. Manual pipetting introduces risks of cross-contamination and variability that are intolerable in workflows dealing with nanoliter-scale reagents and patient samples. Automation secures the experimental integrity needed to analyze complex genetic data, supporting the transition to tailored therapies. In August 2024, Illumina, Inc. reported Core Illumina revenue of $1.09 billion, emphasizing the high volume of genomic sequencing requiring robust liquid handling, while Tecan Group reported sales of CHF 467.2 million, underscoring the enduring demand for life sciences automation.

Market Challenges

The high initial capital required for advanced automated liquid handling systems remains a major obstacle to wider market growth. While large pharmaceutical companies can manage these expenses, smaller biotech firms and academic research centers often face budget constraints that prevent the acquisition of complex robotic platforms. This financial burden is compounded by additional costs for system integration, ongoing maintenance, and specialized staff training. As a result, these economic barriers establish a two-tiered market, preventing a substantial portion of potential users from accessing automation and limiting overall market penetration.

Data from the Pistoia Alliance in 2024 reveals that 20% of life science professionals identified financial barriers as a major challenge to adopting advanced intelligent technologies, a marked rise from 14% the prior year. This increasing trend indicates that budgetary restrictions are directly hindering the industry's technological progress, effectively restricting the scalable implementation of data-integrated automated solutions across various laboratory settings.

Market Trends

The incorporation of Artificial Intelligence and Machine Learning for predictive workflows is evolving liquid handling from static tasks to intelligent, adaptive operations. Unlike traditional automation reliant on fixed scripts, AI-enabled systems utilize operational data to refine scheduling, anticipate maintenance requirements, and minimize downtime from component failures. This transition is vital for addressing workforce shortages that disrupt research and clinical labs, as intelligent systems can autonomously handle routine complexities. In a November 2024 survey by Siemens Healthineers, 91% of laboratory professionals concurred that AI tools effectively address unmet patient care challenges, underscoring the sector's dependence on digital solutions to maintain productivity.

Simultaneously, the shift toward modular and scalable liquid handling architectures is lowering entry barriers for smaller laboratories by superseding large, monolithic platforms with adaptable benchtop solutions. This trend favors user-friendly designs and flexible configurations, enabling researchers to automate specific processes without the massive infrastructure overhauls demanded by legacy systems. By utilizing no-code interfaces and plug-and-play hardware, manufacturers are allowing non-specialist personnel to implement automation quickly, thereby democratizing access to high-precision liquid transfer. For example, Opentrons Labworks announced in September 2024 that their new 'Flex Prep' modular robot allows scientists to configure and run automated pipetting tasks in less than a minute, demonstrating the industry's move toward accessible, high-speed deployment.

Key Players Profiled in the Automated Liquid Handling Technologies Market

• Danaher Corporation
• Thermo Fisher Scientific Inc.
• Agilent Technologies, Inc.
• Aurora Biomed, Inc.
• Autogen, Inc.
• BioTek Instruments, Inc.
• Analytik Jena GmbH+Co. KG
• Corning Incorporated
• Eppendorf SE
• Formulatrix, Inc.

Report Scope

In this report, the Global Automated Liquid Handling Technologies Market has been segmented into the following categories:

Automated Liquid Handling Technologies Market, by Product:

• Workstations
• Accessories

Automated Liquid Handling Technologies Market, by Application:

• Drug Discovery & ADME-Tox Research
• Cancer & Genomic Research
• Bioprocessing/Biotechnology
• Others

Automated Liquid Handling Technologies Market, by End Use:

• Academic & Research Institutes
• Pharmaceutical & Biotechnology Companies
• Contract Research Organizations

Automated Liquid Handling Technologies Market, by Region:

• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Automated Liquid Handling Technologies Market.

Available Customization

The analyst offers customization according to your specific needs. The following customization options are available for the report:

• Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.